Neuroanesthesia & neurocritical care

Selective digestive tract decontamination in critically ill adults with acute brain injuries: a post hoc analysis of a randomized clinical trial

Intensive Care MedPublished Post hoc analysis of a randomised controlled trial

Primary result · In-hospital mortalityResult — go to the resultUnadjusted odds ratio 0.76 95% CI 0.63–0.92

Authors' conclusion

In this post hoc analysis of a randomized clinical trial in critically ill patients with acute brain injuries receiving mechanical ventilation, the use of SDD significantly reduced in-hospital mortality in patients compared to standard care without SDD.

Study context

Population
Mechanically ventilated critically ill adults admitted to the intensive care unit (ICU) with acute brain injuries or conditionsall completed the trial
Participants
2,061 participants
Comparison
SDD vs standard care
  • SDDn = 968
  • Standard caren = 1,093reference
Primary endpoint
In-hospital mortality within 90 days
Follow-up
90 days
Methodological detailscrossover, cluster randomised
  • Crossover
  • Cluster randomised

Primary result

In-hospital mortality

Unadjusted odds ratio

0.76

95% CI 0.63–0.92

P = 0.004

Events by treatment group

SDD vs Standard care
unadjusted OR 0.76 (95% CI 0.63–0.92); P = 0.004

As reported in the abstract

Secondary outcomes

Death in ICU; ventilator-, ICU- and hospital-free days to day 90

Statistically significant improvements in all four secondary outcomes with SDD vs standard care

Heterogeneity of treatment effect, patients with vs without acute brain injuries (subgroup)

No significant heterogeneity of treatment effect
  • Interaction p = 0.22

Original publication

Selective digestive tract decontamination in critically ill adults with acute brain injuries: a post hoc analysis of a randomized clinical trial. Intensive Care Med. Published 20 November 2023. doi:10.1007/s00134-023-07261-y

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.